Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 11 matching records.
11 results — page 1 of 1
- Level AMeta-analysisPubMed
Mesenchymal Stromal Cells for the Treatment of Discogenic Low Back Pain: A Systematic Review of Clinical Studies.
Meta-analysis with a reported sample of 736 on Back Pain, Disc Degeneration, published in Neurospine (2025) — summary generated from the PubMed abstract.
- 2025
- n = 736
Neurospine1 citations - Level ASystematic ReviewPubMed
Stem cells and discogenic back pain.
Systematic Review with a reported sample of 303 on Back Pain, Disc Degeneration, published in Br Med Bull (2023) — summary generated from the PubMed abstract.
- 2023
- n = 303
Br Med Bull - Level AMeta-analysisEurope PMC
Mesenchymal stem cells can improve discogenic pain in patients with intervertebral disc degeneration: a systematic review and meta-analysis
Meta-analysis with a reported sample of 245 on Disc Degeneration, published in Front Bioeng Biotechnol (2023) — summary generated from the PubMed abstract.
- 2023
- n = 245
Front Bioeng Biotechnol12 citations - Level CProspective StudyPubMed
Extracellular vesicle and soluble fractions of adipose tissue-derived mesenchymal stem cells secretome induce inflammatory cytokines modulation in an in vitro model of discogenic pain.
Prospective Study with a reported sample of 3 on Back Pain, Disc Degeneration, Chronic Inflammation, published in Spine J (2022) — summary generated from the PubMed abstract.
- 2022
- n = 3
Spine J - Level CProspective StudyPubMed
Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility study.
Prospective Study on Back Pain, Disc Degeneration, published in Future Sci OA (2022) — summary generated from the PubMed abstract.
- 2022
Future Sci OA13 citations - Level BRandomized Controlled TrialPubMed
Autologous cultured adipose derived mesenchymal stem cells combined with hyaluronic acid hydrogel in the treatment of discogenic low back pain: a study protocol for a phase II randomised controlled trial.
Randomized Controlled Trial on Back Pain, Disc Degeneration, published in BMJ Open (2022) — summary generated from the PubMed abstract.
- 2022
BMJ Open6 citations - Level ASystematic ReviewEurope PMC
The Analgesic Efficacy of Intradiscal Injection of Bone Marrow Aspirate Concentrate and Culture-Expanded Bone Marrow Mesenchymal Stromal Cells in Discogenic Pain: A Systematic Review
Systematic Review with a reported sample of 607 on Back Pain, Disc Degeneration, published in J Pain Res (2022) — summary generated from the PubMed abstract.
- 2022
- n = 607
J Pain Res7 citations - Level DNarrative ReviewEurope PMC
Stem cell therapy in discogenic back pain
Narrative Review on Back Pain, Disc Degeneration, Chronic Inflammation, published in J Spine Surg (2019) — summary generated from the PubMed abstract.
- 2019
J Spine Surg29 citations - Level BClinical TrialPubMed
Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study
Clinical Trial with a reported sample of 5 on Back Pain, Disc Degeneration, Immune Modulation, published in Stem Cell Res Ther (2017) — summary generated from the PubMed abstract.
- 2017
- n = 5
Stem Cell Res Ther148 citations - Level DNarrative ReviewEurope PMC
Multipotent Mesenchymal Stem Cell Treatment for Discogenic Low Back Pain and Disc Degeneration
Narrative Review on Back Pain, Disc Degeneration, published in Stem Cells Int (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells Int39 citations - Level ASystematic ReviewEurope PMC
Notochordal cell-derived therapeutic strategies for discogenic back pain
Systematic Review on Back Pain, published in Global Spine J (2013) — summary generated from the PubMed abstract.
- 2013
Global Spine J29 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406